For 3 weeks, Clara avoided the potential triggers that her GP mentioned, which involved stopping her gymnastic training. However, she still had several flare-ups of rosacea and developed further symptoms, including diarrhoea, fatigue, and weight loss.
Due to Clara's ongoing facial flushing and her new symptoms, the GP decided to request a range of blood tests to investigate other potential underlying pathologies, aside from rosacea:
Clara tested negative for food allergy but was deficient in vitamins D and B12, despite having a balanced diet including meat and fish. In light of the unexplained vitamin B12 deficiency, the GP decided to test for pernicious anaemia with blood tests for antibodies against parietal cells and intrinsic factor, which later returned negative.
Unexplained iron, vitamin B12, or folate deficiency can be a sign of celiac disease.1
Following a repeat tTG IgA test (51 U/mL, 5x ULN), Clara was diagnosed with celiac disease, based on her symptoms, unexplained vitamin B12 deficiency, and elevated tTG IgA.
tTG IgA is the recommended first‑line test for celiac disease, together with total IgA to check for IgA deficiency.2
It is common practice for tTG IgA to be tested every 3 months, until normalised, and once a year as an indicator of diet adherence.2
After 3 months of strict adherence to a gluten-free diet, Clara’s rosacea and celiac disease symptoms had markedly improved. She no longer had troublesome diarrhoea and had regained the weight she previously lost. However, despite Clara's skin no longer feeling tight or itchy, she still had occasional bouts of facial flushing.
Clara told the GP that she now had much more energy and had been able to return to her gymnastics training; she felt that her quality of life had improved to near-normal.
Early diagnosis and treatment of celiac disease with a gluten-free diet implemented in coordination with a dietitian, could:
Clara's repeat blood test results:
Test | Clara's results |
---|---|
Vitamin D | normal (70 nmol/L) |
Vitamin B12 | normal (350 pg/mL) |
tTG IgA | falling (39 U/mL, 4x ULN) |
Tryptase | still mildly elevated (15 mcg/L) |
Due to the elevated tryptase, Clara's GP referred her to a specialist in mast cell disorders.
3 months later, after consultation with a specialist in mast cell disorders, it was revealed that Clara had hereditary alpha-tryptasemia syndrome. This explained the chronically elevated tryptase, and Clara's trouble with persistent facial flushing.
Clara was still adhering to a strict gluten-free diet, and her tTG IgA level had dropped to 31 U/mL (3x ULN).
Clara's tTG IgA level returned to normal in 2019, and she now had annual check-ups with the GP, to monitor diet adherence and symptoms associated with hereditary alpha-tryptasemia syndrome.
Her bowel symptoms and fatigue had entirely resolved on a gluten-free diet, and she was enjoying national success as a gymnast. She decided to leave her full-time office job to pursue a career in gymnastics.
In April 2020, her younger brother was diagnosed with celiac disease at the age of 25 years, after living with intermittent abdominal pain and bloating for several years.
First-degree relatives have a 10 percent chance of developing celiac disease.9
Screening for first-degree relatives, and case-finding in second-degree relatives, can help identify patients earlier, thus reducing the risk of complications.10,11
These results together with this patient's case history and symptoms, help confirm the diagnosis.
Test | Type | <Patients Name> Results |
Test Name | Whole or Component | ## |
Before you proceed ...
We noticed you may be visiting a version of our website that doesn’t match your current location. Would you like to view content based on your region?
Contact us
Interested in utilizing our solutions in your laboratory or healthcare practice?
Not a lab professional or healthcare provider but would like to learn more about allergy testing?
Visit Allergy InsiderChoose your preferred language
Please note: By selecting a different language, you are choosing to view another site. Product availability and indications may vary from what is approved in your region.